![Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches - The Lancet Neurology Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches - The Lancet Neurology](https://www.thelancet.com/cms/attachment/bd645874-312e-4be0-b348-c647904c99b2/gr1.jpg)
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches - The Lancet Neurology
![Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial - The Lancet Neurology Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/e42bfe7e-16bb-42be-9202-b81aa80fe74c/gr1.jpg)
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial - The Lancet Neurology
![Inclusion body myositis in the rheumatology clinic - Balakrishnan - 2020 - International Journal of Rheumatic Diseases - Wiley Online Library Inclusion body myositis in the rheumatology clinic - Balakrishnan - 2020 - International Journal of Rheumatic Diseases - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b151daa5-f6d7-415b-abc0-59eed5ba9542/apl13902-fig-0001-m.jpg)